Medical Gases Market By Product (Pure medical gases, Medical gases mixture), By Application (Therapeutics, Diagnostics, Others), By End User (Hospitals, Pharmaceutical and biotechnology companies, Diagnostic centers, Others): Global Opportunity Analysis and Industry Forecast, 2023-2032

Medical Gases Market

The medical gases market is likely to experience a significant growth rate of 7% from 2023-2032 owing to increasing market demand from healthcare sector –  

Medical gases are used in healthcare facilities to support various medical procedures and treatments. These gases are crucial components that are utilized in healthcare environments for a variety of tasks, such as patient care, diagnostic procedures, and medicinal treatments. The most popular medicinal gas, oxygen, is crucial for patients with respiratory problems because it improves oxygenation and provides crucial breathing support. Furthermore, these gases are essential to the healthcare sector because they assist patient care, anesthesia, surgery, respiratory therapy, and other diagnostic and therapeutic techniques.   

Key factors driving the growth of the medical gases market are attributed to the increase in prevalence of respiratory diseases, rise in number of surgical procedures and rise in adoption of home healthcare. As the prevalence of respiratory disorders such as asthma, COPD, and pneumonia is rising, this has resulted in an increase in demand for medical gases to provide respiratory support to the patients. These conditions often require supplemental oxygen to aid breathing and maintain adequate oxygen levels in the blood. As the number of individuals affected by such respiratory ailments rises, healthcare facilities and providers must ensure an adequate supply of medical gases like oxygen to meet the growing patient needs and improve overall respiratory care outcomes. 

In addition, the rise in adoption of home healthcare is also a key driver for the demand for medical gases. Home healthcare refers to the provision of medical care and treatment in the comfort of a patient's home, allowing individuals to receive necessary medical services without the need for prolonged hospital stays. The growing number of geriatric populations is the major factor for increasing demand for home healthcare. 

Furthermore, the medical gases market is expected to experience significant growth opportunities in developing regions over the next few years. The developing regions are working towards improving their healthcare infrastructure for which they need to set up and expand medical facilities, such as hospitals, clinics and outpatient care centers. This growth in medical facilities creates a need for medical gases, which are needed for patient care and for a variety of medical procedures.  

For example, according to the World Health Organization’s (WHO), “WHO’s Office for Disease Control and Prevention (ODC) is collaborating with the Ministry of Health countries such as Somalia, South Sudan, Chad, Equatorial Guinea and in other countries to develop oxygen plans to meet local needs and to create self-sustaining oxygen supply.” More government initiatives are expected to drive market growth in medical gases. 

The medical gases market is segmented on the basis of product, application, end user, and region. On the basis of product, the market is bifurcated as pure medical gases and medical gases mixture. The pure gases segment is further categorized into oxygen, carbon dioxide, nitrous oxide, nitrogen, and others. Whereas the medical gas mixture segment is further divided into medical air and others. On the basis of application, the market is categorized into therapeutics, diagnostics, and others. By end user, the market is classified into hospitals, pharmaceutical and biotechnology companies, diagnostic centers, and others.  

By region, the market is analyzed across North America (U.S., Canada, and Mexico), Europe (Germany, France, UK, Italy, Spain, and rest of Europe), Asia-Pacific (Japan, China, Australia, India, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Saudi Arabia, and Rest of LAMEA).  

The key players profiled in the study include Air Products and Chemicals, Inc., DCC Plc, Linde plc, Messer Holding GmbH, SOL Spa, Nippon Sanso Holdings Corporation, Air Liquide, PT Samator Indo Gas Tbk., NOL Group and WestAir Gases and Equipment Inc. The players in the market have been actively engaged in the adoption of various strategies such as geographical expansion, agreement, investment, and product launch to remain competitive and gain an advantage over the competitors in the market.  

For instance, in November 2021, Nippon Sanso Holdings Corporation (NSHD), announced the execution of a raw gas supply agreement with Enlink Midstream, LLC and will also be constructing a state-of-the-art facility in Texas dedicated to the production of liquefied carbon dioxide and dry ice. 

Key Market Insights 

By application, the therapeutics segment dominated the global market and is expected to be the fastest-growing segment during the forecast period. 

By end user, the hospitals segment dominated the market in 2022, whereas the others segment is anticipated to grow at a fastest rate during the forecast period.  

Based on region, North America garnered the largest revenue share in 2022, and Asia-Pacific is anticipated to grow at the highest CAGR during the forecast period. 

 

Overview

The medical gases market was valued at $8.5 billion in 2022 and is estimated to reach $16.7 billion by 2032, exhibiting a CAGR of 7% from 2023 to 2032. Medical gases refer to gases that are used in medical procedures, treatments, and therapies to support patient care. These gases play a crucial role in the functioning of hospitals and various healthcare facilities. Hospital medical gas systems necessitate the use of various types of gases, each possessing distinct properties and serving specific purposes. These gases are specifically manufactured, purified, and regulated to meet the stringent standards of medical use. Also, these gases, which are essential for medical procedures, are supplied in medical facilities through specialized systems designed for each gas. These gases are transported through a network of pipes from a central supply source. In some cases, certain gases with low volumes may be supplied either in cylinders. 

Medical gases are available in two types, pure medical gases and the mixture of gases. Pure medical gases are gases that are specifically manufactured and purified to meet the stringent standards of medical use. These gases are essential for various medical applications and therapies. Examples of pure medical gases include oxygen, nitrogen, carbon dioxide, helium, and others. On the other hand, mixtures of medical gases are combinations of different pure gases in different compositions used for specific medical applications. Some examples of mixture medical gases include medical air, calibration gases, heliox, and others. 

The medical gases market is driven by the high demand for essential gases in the healthcare sector. Oxygen, being the most widely used medical gas, plays a critical role in supporting patients with respiratory conditions. Nitrous oxide serves as an important anesthetic during surgical procedures, while helium facilitates easier breathing for patients. In addition, carbon dioxide gas is used in medical procedures like laparoscopy and hysteroscopy, where it is used to inflate the abdominal cavity or uterus. The diagnostic and treatment need of patients necessitate the use of various medical gases, leading to a substantial demand in the healthcare industry. This increase in demand for medical gases fuels the growth of the medical gases market. 

Furthermore, factors that drive the growth of the global medical gases market include an increase in the number of patients suffering from chronic obstructive pulmonary disease (COPD), asthma, and other respiratory diseases. For instance, according to the Centers for Disease Control and Prevention (CDC), the number of visits to emergency departments with COPD as the primary diagnosis was 1.2 million in 2020 in the U.S. Prevalence of chronic and acute conditions such as COPD, pulmonary fibrosis, pneumonia, cystic fibrosis, and others which require medical gases in the diagnosis or treatment is propelling the growth of the market. 

However, the medical gases market faces certain restraints that may impede its growth and development. The production and supply of medical gases have stringent regulations to ensure the safety, quality, and reliability of these critical healthcare products. These regulations aim to safeguard patient well-being and maintain the integrity of medical gas systems. Medical gas manufacturers are expected to adhere to GMP guidelines, which establish stringent quality control measures for the production, handling, storage, and distribution of medical gases. This is projected to hinder the medical gases market growth. 

On the contrary, the growth of the market is expected to be driven by developing regions. In developing regions, healthcare infrastructure is often underdeveloped than in more developed regions. As a result, developing regions are investing or collaborating in the development and expansion of healthcare facilities, such as hospitals, clinics and outpatient care centers. The development of these facilities creates a need for medical gases to provide patient care with a wide range of medical procedures. This is anticipated to create a lucrative opportunity for market growth. 

The medical gases market is segmented on the basis of product, application, end user, and region. On the basis of product, the market is bifurcated as pure medical gases and medical gases mixture. The pure gases segment is further categorized into oxygen, carbon dioxide, nitrous oxide, nitrogen, and others. Whereas the medical gas mixture segment is further divided into medical air and others. On the basis of application, the market is categorized into therapeutics, diagnostics, and others. By end user, the market is classified into hospitals, pharmaceutical and biotechnology companies, diagnostic centers, and others. 

By region, the market is analyzed across North America (U.S., Canada, and Mexico), Europe (Germany, France, UK, Italy, Spain, and rest of Europe), Asia-Pacific (Japan, China, Australia, India, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Saudi Arabia, and Rest of LAMEA). Major players that operate in the market include Air Products and Chemicals, Inc., DCC Plc, Linde plc, Messer Holding GmbH, SOL Spa, Nippon Sanso Holdings Corporation, Air Liquide, PT Samator Indo Gas Tbk., NOL Group and WestAir Gases and Equipment Inc.  

Key Benefits For Stakeholders

●This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the medical gases market analysis from 2022 to 2032 to identify the prevailing medical gases market opportunities.

●The market research is offered along with information related to key drivers, restraints, and opportunities.

●Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.

●In-depth analysis of the medical gases market segmentation assists to determine the prevailing market opportunities.

●Major countries in each region are mapped according to their revenue contribution to the global market.

●Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.

●The report includes the analysis of the regional as well as global medical gases market trends, key players, market segments, application areas, and market growth strategies.

Additional benefits you will get with this purchase are:

● Quarterly Update and* (only available with a corporate license, on listed price)

● 5 additional Company Profile of client Choice pre- or Post-purchase, as a free update.

● Free Upcoming Version on the Purchase of Five and Enterprise User License.

● 16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)

● 15% Free Customization* (in case the scope or segment of the report does not match your requirements, 20% is equivalent to 3 working days of free work, applicable once)

● Free data Pack on the Five and Enterprise User License. (Excel version of the report)

● Free Updated report if the report is 6-12 months old or older.

● 24-hour priority response*

● Free Industry updates and white papers.

Possible Customization with this report (with additional cost and timeline talk to the sales executive to know more)

● Regulatory Guidelines

● Additional company profiles with specific to client's interest

● Additional country or region analysis- market size and forecast

● Expanded list for Company Profiles

● Historic market data

● Key player details (including location, contact details, supplier/vendor network etc. in excel format)

Key Market Segments

○ NOL Grou

Scope of Medical Gases Market Report

1.1. Report description

1.2. Key market segments

1.3. Key benefits to the stakeholders

1.4. Research Methodology

1.4.1. Primary research

1.4.2. Secondary research

1.4.3. Analyst tools and models

2.1. CXO Perspective

3.1. Market definition and scope

3.2. Key findings

3.2.1. Top impacting factors

3.2.2. Top investment pockets

3.3. Porter’s five forces analysis

3.3.1. Low bargaining power of suppliers

3.3.2. Moderate threat of new entrants

3.3.3. Low threat of substitutes

3.3.4. Low intensity of rivalry

3.3.5. Low bargaining power of buyers

3.4. Market dynamics

3.4.1. Drivers

3.4.1.1. Increase in prevalence of respiratory diseases

3.4.1.2. Rise in number of surgical procedures

3.4.1.3. Rise in adoption of Home Healthcare

3.4.2. Restraints

3.4.2.1. Stringent regulations for manufacturing and supply of medical gas

3.4.3. Opportunities

3.4.3.1. Growth opportunities in developing regions

3.5. COVID-19 Impact Analysis on the market

4.1. Overview

4.1.1. Market size and forecast

4.2. Pure medical gases

4.2.1. Key market trends, growth factors and opportunities

4.2.2. Market size and forecast, by region

4.2.3. Market share analysis by country

4.2.4. Pure medical gases Medical Gases Market by Type

4.3. Medical gases mixture

4.3.1. Key market trends, growth factors and opportunities

4.3.2. Market size and forecast, by region

4.3.3. Market share analysis by country

4.3.4. Medical gases mixture Medical Gases Market by Type

5.1. Overview

5.1.1. Market size and forecast

5.2. Therapeutics

5.2.1. Key market trends, growth factors and opportunities

5.2.2. Market size and forecast, by region

5.2.3. Market share analysis by country

5.3. Diagnostics

5.3.1. Key market trends, growth factors and opportunities

5.3.2. Market size and forecast, by region

5.3.3. Market share analysis by country

5.4. Others

5.4.1. Key market trends, growth factors and opportunities

5.4.2. Market size and forecast, by region

5.4.3. Market share analysis by country

6.1. Overview

6.1.1. Market size and forecast

6.2. Hospitals

6.2.1. Key market trends, growth factors and opportunities

6.2.2. Market size and forecast, by region

6.2.3. Market share analysis by country

6.3. Pharmaceutical and biotechnology companies

6.3.1. Key market trends, growth factors and opportunities

6.3.2. Market size and forecast, by region

6.3.3. Market share analysis by country

6.4. Diagnostic centers

6.4.1. Key market trends, growth factors and opportunities

6.4.2. Market size and forecast, by region

6.4.3. Market share analysis by country

6.5. Others

6.5.1. Key market trends, growth factors and opportunities

6.5.2. Market size and forecast, by region

6.5.3. Market share analysis by country

7.1. Overview

7.1.1. Market size and forecast By Region

7.2. North America

7.2.1. Key trends and opportunities

7.2.2. Market size and forecast, by Product

7.2.3. Market size and forecast, by Application

7.2.4. Market size and forecast, by End User

7.2.5. Market size and forecast, by country

7.2.5.1. U.S.

7.2.5.1.1. Key market trends, growth factors and opportunities

7.2.5.1.2. Market size and forecast, by Product

7.2.5.1.3. Market size and forecast, by Application

7.2.5.1.4. Market size and forecast, by End User

7.2.5.2. Canada

7.2.5.2.1. Key market trends, growth factors and opportunities

7.2.5.2.2. Market size and forecast, by Product

7.2.5.2.3. Market size and forecast, by Application

7.2.5.2.4. Market size and forecast, by End User

7.2.5.3. Mexico

7.2.5.3.1. Key market trends, growth factors and opportunities

7.2.5.3.2. Market size and forecast, by Product

7.2.5.3.3. Market size and forecast, by Application

7.2.5.3.4. Market size and forecast, by End User

7.3. Europe

7.3.1. Key trends and opportunities

7.3.2. Market size and forecast, by Product

7.3.3. Market size and forecast, by Application

7.3.4. Market size and forecast, by End User

7.3.5. Market size and forecast, by country

7.3.5.1. Germany

7.3.5.1.1. Key market trends, growth factors and opportunities

7.3.5.1.2. Market size and forecast, by Product

7.3.5.1.3. Market size and forecast, by Application

7.3.5.1.4. Market size and forecast, by End User

7.3.5.2. France

7.3.5.2.1. Key market trends, growth factors and opportunities

7.3.5.2.2. Market size and forecast, by Product

7.3.5.2.3. Market size and forecast, by Application

7.3.5.2.4. Market size and forecast, by End User

7.3.5.3. UK

7.3.5.3.1. Key market trends, growth factors and opportunities

7.3.5.3.2. Market size and forecast, by Product

7.3.5.3.3. Market size and forecast, by Application

7.3.5.3.4. Market size and forecast, by End User

7.3.5.4. Italy

7.3.5.4.1. Key market trends, growth factors and opportunities

7.3.5.4.2. Market size and forecast, by Product

7.3.5.4.3. Market size and forecast, by Application

7.3.5.4.4. Market size and forecast, by End User

7.3.5.5. Spain

7.3.5.5.1. Key market trends, growth factors and opportunities

7.3.5.5.2. Market size and forecast, by Product

7.3.5.5.3. Market size and forecast, by Application

7.3.5.5.4. Market size and forecast, by End User

7.3.5.6. Rest of Europe

7.3.5.6.1. Key market trends, growth factors and opportunities

7.3.5.6.2. Market size and forecast, by Product

7.3.5.6.3. Market size and forecast, by Application

7.3.5.6.4. Market size and forecast, by End User

7.4. Asia-Pacific

7.4.1. Key trends and opportunities

7.4.2. Market size and forecast, by Product

7.4.3. Market size and forecast, by Application

7.4.4. Market size and forecast, by End User

7.4.5. Market size and forecast, by country

7.4.5.1. Japan

7.4.5.1.1. Key market trends, growth factors and opportunities

7.4.5.1.2. Market size and forecast, by Product

7.4.5.1.3. Market size and forecast, by Application

7.4.5.1.4. Market size and forecast, by End User

7.4.5.2. China

7.4.5.2.1. Key market trends, growth factors and opportunities

7.4.5.2.2. Market size and forecast, by Product

7.4.5.2.3. Market size and forecast, by Application

7.4.5.2.4. Market size and forecast, by End User

7.4.5.3. India

7.4.5.3.1. Key market trends, growth factors and opportunities

7.4.5.3.2. Market size and forecast, by Product

7.4.5.3.3. Market size and forecast, by Application

7.4.5.3.4. Market size and forecast, by End User

7.4.5.4. Australia

7.4.5.4.1. Key market trends, growth factors and opportunities

7.4.5.4.2. Market size and forecast, by Product

7.4.5.4.3. Market size and forecast, by Application

7.4.5.4.4. Market size and forecast, by End User

7.4.5.5. South Korea

7.4.5.5.1. Key market trends, growth factors and opportunities

7.4.5.5.2. Market size and forecast, by Product

7.4.5.5.3. Market size and forecast, by Application

7.4.5.5.4. Market size and forecast, by End User

7.4.5.6. Rest of Asia-Pacific

7.4.5.6.1. Key market trends, growth factors and opportunities

7.4.5.6.2. Market size and forecast, by Product

7.4.5.6.3. Market size and forecast, by Application

7.4.5.6.4. Market size and forecast, by End User

7.5. LAMEA

7.5.1. Key trends and opportunities

7.5.2. Market size and forecast, by Product

7.5.3. Market size and forecast, by Application

7.5.4. Market size and forecast, by End User

7.5.5. Market size and forecast, by country

7.5.5.1. Brazil

7.5.5.1.1. Key market trends, growth factors and opportunities

7.5.5.1.2. Market size and forecast, by Product

7.5.5.1.3. Market size and forecast, by Application

7.5.5.1.4. Market size and forecast, by End User

7.5.5.2. Saudi Arabia

7.5.5.2.1. Key market trends, growth factors and opportunities

7.5.5.2.2. Market size and forecast, by Product

7.5.5.2.3. Market size and forecast, by Application

7.5.5.2.4. Market size and forecast, by End User

7.5.5.3. South Africa

7.5.5.3.1. Key market trends, growth factors and opportunities

7.5.5.3.2. Market size and forecast, by Product

7.5.5.3.3. Market size and forecast, by Application

7.5.5.3.4. Market size and forecast, by End User

7.5.5.4. Rest of LAMEA

7.5.5.4.1. Key market trends, growth factors and opportunities

7.5.5.4.2. Market size and forecast, by Product

7.5.5.4.3. Market size and forecast, by Application

7.5.5.4.4. Market size and forecast, by End User

8.1. Introduction

8.2. Top winning strategies

8.3. Product Mapping of Top 10 Player

8.4. Competitive Dashboard

8.5. Competitive Heatmap

8.6. Top player positioning, 2022

9.1. Nippon Sanso Holdings Corporation

9.1.1. Company overview

9.1.2. Key Executives

9.1.3. Company snapshot

9.1.4. Operating business segments

9.1.5. Product portfolio

9.1.6. Business performance

9.1.7. Key strategic moves and developments

9.2. Air Products and Chemicals, Inc.

9.2.1. Company overview

9.2.2. Key Executives

9.2.3. Company snapshot

9.2.4. Operating business segments

9.2.5. Product portfolio

9.2.6. Business performance

9.3. DCC Plc

9.3.1. Company overview

9.3.2. Key Executives

9.3.3. Company snapshot

9.3.4. Operating business segments

9.3.5. Product portfolio

9.3.6. Business performance

9.4. Linde plc

9.4.1. Company overview

9.4.2. Key Executives

9.4.3. Company snapshot

9.4.4. Operating business segments

9.4.5. Product portfolio

9.4.6. Business performance

9.5. Messer Holding GmbH

9.5.1. Company overview

9.5.2. Key Executives

9.5.3. Company snapshot

9.5.4. Operating business segments

9.5.5. Product portfolio

9.5.6. Business performance

9.6. PT Samator Indo Gas Tbk.

9.6.1. Company overview

9.6.2. Key Executives

9.6.3. Company snapshot

9.6.4. Operating business segments

9.6.5. Product portfolio

9.6.6. Business performance

9.7. NOL Group

9.7.1. Company overview

9.7.2. Key Executives

9.7.3. Company snapshot

9.7.4. Operating business segments

9.7.5. Product portfolio

9.7.6. Business performance

9.8. SOL Spa

9.8.1. Company overview

9.8.2. Key Executives

9.8.3. Company snapshot

9.8.4. Operating business segments

9.8.5. Product portfolio

9.8.6. Business performance

9.8.7. Key strategic moves and developments

9.9. Air Liquide

9.9.1. Company overview

9.9.2. Key Executives

9.9.3. Company snapshot

9.9.4. Operating business segments

9.9.5. Product portfolio

9.9.6. Business performance

9.10. WestAir Gases And Equipment Inc.

9.10.1. Company overview

9.10.2. Key Executives

9.10.3. Company snapshot

9.10.4. Operating business segments

9.10.5. Product portfoli

LIST OF TABLES

TABLE 01. GLOBAL MEDICAL GASES MARKET, BY PRODUCT, 2022-2032 ($MILLION)

TABLE 02. MEDICAL GASES MARKET FOR PURE MEDICAL GASES, BY REGION, 2022-2032 ($MILLION)

TABLE 03. GLOBAL PURE MEDICAL GASES MEDICAL GASES MARKET, BY TYPE, 2022-2032 ($MILLION)

TABLE 04. MEDICAL GASES MARKET FOR MEDICAL GASES MIXTURE, BY REGION, 2022-2032 ($MILLION)

TABLE 05. GLOBAL MEDICAL GASES MIXTURE MEDICAL GASES MARKET, BY TYPE, 2022-2032 ($MILLION)

TABLE 06. GLOBAL MEDICAL GASES MARKET, BY APPLICATION, 2022-2032 ($MILLION)

TABLE 07. MEDICAL GASES MARKET FOR THERAPEUTICS, BY REGION, 2022-2032 ($MILLION)

TABLE 08. MEDICAL GASES MARKET FOR DIAGNOSTICS, BY REGION, 2022-2032 ($MILLION)

TABLE 09. MEDICAL GASES MARKET FOR OTHERS, BY REGION, 2022-2032 ($MILLION)

TABLE 10. GLOBAL MEDICAL GASES MARKET, BY END USER, 2022-2032 ($MILLION)

TABLE 11. MEDICAL GASES MARKET FOR HOSPITALS, BY REGION, 2022-2032 ($MILLION)

TABLE 12. MEDICAL GASES MARKET FOR PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY REGION, 2022-2032 ($MILLION)

TABLE 13. MEDICAL GASES MARKET FOR DIAGNOSTIC CENTERS, BY REGION, 2022-2032 ($MILLION)

TABLE 14. MEDICAL GASES MARKET FOR OTHERS, BY REGION, 2022-2032 ($MILLION)

TABLE 15. MEDICAL GASES MARKET, BY REGION, 2022-2032 ($MILLION)

TABLE 16. NORTH AMERICA MEDICAL GASES MARKET, BY PRODUCT, 2022-2032 ($MILLION)

TABLE 17. NORTH AMERICA MEDICAL GASES MARKET, BY APPLICATION, 2022-2032 ($MILLION)

TABLE 18. NORTH AMERICA MEDICAL GASES MARKET, BY END USER, 2022-2032 ($MILLION)

TABLE 19. NORTH AMERICA MEDICAL GASES MARKET, BY COUNTRY, 2022-2032 ($MILLION)

TABLE 20. U.S. MEDICAL GASES MARKET, BY PRODUCT, 2022-2032 ($MILLION)

TABLE 21. U.S. MEDICAL GASES MARKET, BY APPLICATION, 2022-2032 ($MILLION)

TABLE 22. U.S. MEDICAL GASES MARKET, BY END USER, 2022-2032 ($MILLION)

TABLE 23. CANADA MEDICAL GASES MARKET, BY PRODUCT, 2022-2032 ($MILLION)

TABLE 24. CANADA MEDICAL GASES MARKET, BY APPLICATION, 2022-2032 ($MILLION)

TABLE 25. CANADA MEDICAL GASES MARKET, BY END USER, 2022-2032 ($MILLION)

TABLE 26. MEXICO MEDICAL GASES MARKET, BY PRODUCT, 2022-2032 ($MILLION)

TABLE 27. MEXICO MEDICAL GASES MARKET, BY APPLICATION, 2022-2032 ($MILLION)

TABLE 28. MEXICO MEDICAL GASES MARKET, BY END USER, 2022-2032 ($MILLION)

TABLE 29. EUROPE MEDICAL GASES MARKET, BY PRODUCT, 2022-2032 ($MILLION)

TABLE 30. EUROPE MEDICAL GASES MARKET, BY APPLICATION, 2022-2032 ($MILLION)

TABLE 31. EUROPE MEDICAL GASES MARKET, BY END USER, 2022-2032 ($MILLION)

TABLE 32. EUROPE MEDICAL GASES MARKET, BY COUNTRY, 2022-2032 ($MILLION)

TABLE 33. GERMANY MEDICAL GASES MARKET, BY PRODUCT, 2022-2032 ($MILLION)

TABLE 34. GERMANY MEDICAL GASES MARKET, BY APPLICATION, 2022-2032 ($MILLION)

TABLE 35. GERMANY MEDICAL GASES MARKET, BY END USER, 2022-2032 ($MILLION)

TABLE 36. FRANCE MEDICAL GASES MARKET, BY PRODUCT, 2022-2032 ($MILLION)

TABLE 37. FRANCE MEDICAL GASES MARKET, BY APPLICATION, 2022-2032 ($MILLION)

TABLE 38. FRANCE MEDICAL GASES MARKET, BY END USER, 2022-2032 ($MILLION)

TABLE 39. UK MEDICAL GASES MARKET, BY PRODUCT, 2022-2032 ($MILLION)

TABLE 40. UK MEDICAL GASES MARKET, BY APPLICATION, 2022-2032 ($MILLION)

TABLE 41. UK MEDICAL GASES MARKET, BY END USER, 2022-2032 ($MILLION)

TABLE 42. ITALY MEDICAL GASES MARKET, BY PRODUCT, 2022-2032 ($MILLION)

TABLE 43. ITALY MEDICAL GASES MARKET, BY APPLICATION, 2022-2032 ($MILLION)

TABLE 44. ITALY MEDICAL GASES MARKET, BY END USER, 2022-2032 ($MILLION)

TABLE 45. SPAIN MEDICAL GASES MARKET, BY PRODUCT, 2022-2032 ($MILLION)

TABLE 46. SPAIN MEDICAL GASES MARKET, BY APPLICATION, 2022-2032 ($MILLION)

TABLE 47. SPAIN MEDICAL GASES MARKET, BY END USER, 2022-2032 ($MILLION)

TABLE 48. REST OF EUROPE MEDICAL GASES MARKET, BY PRODUCT, 2022-2032 ($MILLION)

TABLE 49. REST OF EUROPE MEDICAL GASES MARKET, BY APPLICATION, 2022-2032 ($MILLION)

TABLE 50. REST OF EUROPE MEDICAL GASES MARKET, BY END USER, 2022-2032 ($MILLION)

TABLE 51. ASIA-PACIFIC MEDICAL GASES MARKET, BY PRODUCT, 2022-2032 ($MILLION)

TABLE 52. ASIA-PACIFIC MEDICAL GASES MARKET, BY APPLICATION, 2022-2032 ($MILLION)

TABLE 53. ASIA-PACIFIC MEDICAL GASES MARKET, BY END USER, 2022-2032 ($MILLION)

TABLE 54. ASIA-PACIFIC MEDICAL GASES MARKET, BY COUNTRY, 2022-2032 ($MILLION)

TABLE 55. JAPAN MEDICAL GASES MARKET, BY PRODUCT, 2022-2032 ($MILLION)

TABLE 56. JAPAN MEDICAL GASES MARKET, BY APPLICATION, 2022-2032 ($MILLION)

TABLE 57. JAPAN MEDICAL GASES MARKET, BY END USER, 2022-2032 ($MILLION)

TABLE 58. CHINA MEDICAL GASES MARKET, BY PRODUCT, 2022-2032 ($MILLION)

TABLE 59. CHINA MEDICAL GASES MARKET, BY APPLICATION, 2022-2032 ($MILLION)

TABLE 60. CHINA MEDICAL GASES MARKET, BY END USER, 2022-2032 ($MILLION)

TABLE 61. INDIA MEDICAL GASES MARKET, BY PRODUCT, 2022-2032 ($MILLION)

TABLE 62. INDIA MEDICAL GASES MARKET, BY APPLICATION, 2022-2032 ($MILLION)

TABLE 63. INDIA MEDICAL GASES MARKET, BY END USER, 2022-2032 ($MILLION)

TABLE 64. AUSTRALIA MEDICAL GASES MARKET, BY PRODUCT, 2022-2032 ($MILLION)

TABLE 65. AUSTRALIA MEDICAL GASES MARKET, BY APPLICATION, 2022-2032 ($MILLION)

TABLE 66. AUSTRALIA MEDICAL GASES MARKET, BY END USER, 2022-2032 ($MILLION)

TABLE 67. SOUTH KOREA MEDICAL GASES MARKET, BY PRODUCT, 2022-2032 ($MILLION)

TABLE 68. SOUTH KOREA MEDICAL GASES MARKET, BY APPLICATION, 2022-2032 ($MILLION)

TABLE 69. SOUTH KOREA MEDICAL GASES MARKET, BY END USER, 2022-2032 ($MILLION)

TABLE 70. REST OF ASIA-PACIFIC MEDICAL GASES MARKET, BY PRODUCT, 2022-2032 ($MILLION)

TABLE 71. REST OF ASIA-PACIFIC MEDICAL GASES MARKET, BY APPLICATION, 2022-2032 ($MILLION)

TABLE 72. REST OF ASIA-PACIFIC MEDICAL GASES MARKET, BY END USER, 2022-2032 ($MILLION)

TABLE 73. LAMEA MEDICAL GASES MARKET, BY PRODUCT, 2022-2032 ($MILLION)

TABLE 74. LAMEA MEDICAL GASES MARKET, BY APPLICATION, 2022-2032 ($MILLION)

TABLE 75. LAMEA MEDICAL GASES MARKET, BY END USER, 2022-2032 ($MILLION)

TABLE 76. LAMEA MEDICAL GASES MARKET, BY COUNTRY, 2022-2032 ($MILLION)

TABLE 77. BRAZIL MEDICAL GASES MARKET, BY PRODUCT, 2022-2032 ($MILLION)

TABLE 78. BRAZIL MEDICAL GASES MARKET, BY APPLICATION, 2022-2032 ($MILLION)

TABLE 79. BRAZIL MEDICAL GASES MARKET, BY END USER, 2022-2032 ($MILLION)

TABLE 80. SAUDI ARABIA MEDICAL GASES MARKET, BY PRODUCT, 2022-2032 ($MILLION)

TABLE 81. SAUDI ARABIA MEDICAL GASES MARKET, BY APPLICATION, 2022-2032 ($MILLION)

TABLE 82. SAUDI ARABIA MEDICAL GASES MARKET, BY END USER, 2022-2032 ($MILLION)

TABLE 83. SOUTH AFRICA MEDICAL GASES MARKET, BY PRODUCT, 2022-2032 ($MILLION)

TABLE 84. SOUTH AFRICA MEDICAL GASES MARKET, BY APPLICATION, 2022-2032 ($MILLION)

TABLE 85. SOUTH AFRICA MEDICAL GASES MARKET, BY END USER, 2022-2032 ($MILLION)

TABLE 86. REST OF LAMEA MEDICAL GASES MARKET, BY PRODUCT, 2022-2032 ($MILLION)

TABLE 87. REST OF LAMEA MEDICAL GASES MARKET, BY APPLICATION, 2022-2032 ($MILLION)

TABLE 88. REST OF LAMEA MEDICAL GASES MARKET, BY END USER, 2022-2032 ($MILLION)

TABLE 89. NIPPON SANSO HOLDINGS CORPORATION: KEY EXECUTIVES

TABLE 90. NIPPON SANSO HOLDINGS CORPORATION: COMPANY SNAPSHOT

TABLE 91. NIPPON SANSO HOLDINGS CORPORATION: PRODUCT SEGMENTS

TABLE 92. NIPPON SANSO HOLDINGS CORPORATION: PRODUCT PORTFOLIO

TABLE 93. NIPPON SANSO HOLDINGS CORPORATION: KEY STRATERGIES

TABLE 94. AIR PRODUCTS AND CHEMICALS, INC.: KEY EXECUTIVES

TABLE 95. AIR PRODUCTS AND CHEMICALS, INC.: COMPANY SNAPSHOT

TABLE 96. AIR PRODUCTS AND CHEMICALS, INC.: PRODUCT SEGMENTS

TABLE 97. AIR PRODUCTS AND CHEMICALS, INC.: PRODUCT PORTFOLIO

TABLE 98. DCC PLC: KEY EXECUTIVES

TABLE 99. DCC PLC: COMPANY SNAPSHOT

TABLE 100. DCC PLC: PRODUCT SEGMENTS

TABLE 101. DCC PLC: PRODUCT PORTFOLIO

TABLE 102. LINDE PLC: KEY EXECUTIVES

TABLE 103. LINDE PLC: COMPANY SNAPSHOT

TABLE 104. LINDE PLC: PRODUCT SEGMENTS

TABLE 105. LINDE PLC: PRODUCT PORTFOLIO

TABLE 106. MESSER HOLDING GMBH: KEY EXECUTIVES

TABLE 107. MESSER HOLDING GMBH: COMPANY SNAPSHOT

TABLE 108. MESSER HOLDING GMBH: PRODUCT SEGMENTS

TABLE 109. MESSER HOLDING GMBH: PRODUCT PORTFOLIO

TABLE 110. PT SAMATOR INDO GAS TBK.: KEY EXECUTIVES

TABLE 111. PT SAMATOR INDO GAS TBK.: COMPANY SNAPSHOT

TABLE 112. PT SAMATOR INDO GAS TBK.: PRODUCT SEGMENTS

TABLE 113. PT SAMATOR INDO GAS TBK.: PRODUCT PORTFOLIO

TABLE 114. NOL GROUP: KEY EXECUTIVES

TABLE 115. NOL GROUP: COMPANY SNAPSHOT

TABLE 116. NOL GROUP: PRODUCT SEGMENTS

TABLE 117. NOL GROUP: PRODUCT PORTFOLIO

TABLE 118. SOL SPA: KEY EXECUTIVES

TABLE 119. SOL SPA: COMPANY SNAPSHOT

TABLE 120. SOL SPA: PRODUCT SEGMENTS

TABLE 121. SOL SPA: PRODUCT PORTFOLIO

TABLE 122. SOL SPA: KEY STRATERGIES

TABLE 123. AIR LIQUIDE: KEY EXECUTIVES

TABLE 124. AIR LIQUIDE: COMPANY SNAPSHOT

TABLE 125. AIR LIQUIDE: PRODUCT SEGMENTS

TABLE 126. AIR LIQUIDE: PRODUCT PORTFOLIO

TABLE 127. WESTAIR GASES AND EQUIPMENT INC.: KEY EXECUTIVES

TABLE 128. WESTAIR GASES AND EQUIPMENT INC.: COMPANY SNAPSHOT

TABLE 129. WESTAIR GASES AND EQUIPMENT INC.: PRODUCT SEGMENTS

TABLE 130. WESTAIR GASES AND EQUIPMENT INC.: PRODUCT PORTFOLIO LIST OF FIGURES

FIGURE 01. MEDICAL GASES MARKET, 2022-2032

FIGURE 02. SEGMENTATION OF MEDICAL GASES MARKET,2022-2032

FIGURE 03. TOP INVESTMENT POCKETS IN MEDICAL GASES MARKET (2023-2032)

FIGURE 04. LOW BARGAINING POWER OF SUPPLIERS

FIGURE 05. MODERATE THREAT OF NEW ENTRANTS

FIGURE 06. LOW THREAT OF SUBSTITUTES

FIGURE 07. LOW INTENSITY OF RIVALRY

FIGURE 08. LOW BARGAINING POWER OF BUYERS

FIGURE 09. GLOBAL MEDICAL GASES MARKET:DRIVERS, RESTRAINTS AND OPPORTUNITIES

FIGURE 10. MEDICAL GASES MARKET, BY PRODUCT, 2022(%)

FIGURE 11. COMPARATIVE SHARE ANALYSIS OF MEDICAL GASES MARKET FOR PURE MEDICAL GASES, BY COUNTRY 2022 AND 2032(%)

FIGURE 12. COMPARATIVE SHARE ANALYSIS OF MEDICAL GASES MARKET FOR MEDICAL GASES MIXTURE, BY COUNTRY 2022 AND 2032(%)

FIGURE 13. MEDICAL GASES MARKET, BY APPLICATION, 2022(%)

FIGURE 14. COMPARATIVE SHARE ANALYSIS OF MEDICAL GASES MARKET FOR THERAPEUTICS, BY COUNTRY 2022 AND 2032(%)

FIGURE 15. COMPARATIVE SHARE ANALYSIS OF MEDICAL GASES MARKET FOR DIAGNOSTICS, BY COUNTRY 2022 AND 2032(%)

FIGURE 16. COMPARATIVE SHARE ANALYSIS OF MEDICAL GASES MARKET FOR OTHERS, BY COUNTRY 2022 AND 2032(%)

FIGURE 17. MEDICAL GASES MARKET, BY END USER, 2022(%)

FIGURE 18. COMPARATIVE SHARE ANALYSIS OF MEDICAL GASES MARKET FOR HOSPITALS, BY COUNTRY 2022 AND 2032(%)

FIGURE 19. COMPARATIVE SHARE ANALYSIS OF MEDICAL GASES MARKET FOR PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY COUNTRY 2022 AND 2032(%)

FIGURE 20. COMPARATIVE SHARE ANALYSIS OF MEDICAL GASES MARKET FOR DIAGNOSTIC CENTERS, BY COUNTRY 2022 AND 2032(%)

FIGURE 21. COMPARATIVE SHARE ANALYSIS OF MEDICAL GASES MARKET FOR OTHERS, BY COUNTRY 2022 AND 2032(%)

FIGURE 22. MEDICAL GASES MARKET BY REGION, 2022(%)

FIGURE 23. U.S. MEDICAL GASES MARKET, 2022-2032 ($MILLION)

FIGURE 24. CANADA MEDICAL GASES MARKET, 2022-2032 ($MILLION)

FIGURE 25. MEXICO MEDICAL GASES MARKET, 2022-2032 ($MILLION)

FIGURE 26. GERMANY MEDICAL GASES MARKET, 2022-2032 ($MILLION)

FIGURE 27. FRANCE MEDICAL GASES MARKET, 2022-2032 ($MILLION)

FIGURE 28. UK MEDICAL GASES MARKET, 2022-2032 ($MILLION)

FIGURE 29. ITALY MEDICAL GASES MARKET, 2022-2032 ($MILLION)

FIGURE 30. SPAIN MEDICAL GASES MARKET, 2022-2032 ($MILLION)

FIGURE 31. REST OF EUROPE MEDICAL GASES MARKET, 2022-2032 ($MILLION)

FIGURE 32. JAPAN MEDICAL GASES MARKET, 2022-2032 ($MILLION)

FIGURE 33. CHINA MEDICAL GASES MARKET, 2022-2032 ($MILLION)

FIGURE 34. INDIA MEDICAL GASES MARKET, 2022-2032 ($MILLION)

FIGURE 35. AUSTRALIA MEDICAL GASES MARKET, 2022-2032 ($MILLION)

FIGURE 36. SOUTH KOREA MEDICAL GASES MARKET, 2022-2032 ($MILLION)

FIGURE 37. REST OF ASIA-PACIFIC MEDICAL GASES MARKET, 2022-2032 ($MILLION)

FIGURE 38. BRAZIL MEDICAL GASES MARKET, 2022-2032 ($MILLION)

FIGURE 39. SAUDI ARABIA MEDICAL GASES MARKET, 2022-2032 ($MILLION)

FIGURE 40. SOUTH AFRICA MEDICAL GASES MARKET, 2022-2032 ($MILLION)

FIGURE 41. REST OF LAMEA MEDICAL GASES MARKET, 2022-2032 ($MILLION)

FIGURE 42. TOP WINNING STRATEGIES, BY YEAR

FIGURE 43. TOP WINNING STRATEGIES, BY DEVELOPMENT

FIGURE 44. TOP WINNING STRATEGIES, BY COMPANY

FIGURE 45. PRODUCT MAPPING OF TOP 10 PLAYERS

FIGURE 46. COMPETITIVE DASHBOARD

FIGURE 47. COMPETITIVE HEATMAP: MEDICAL GASES MARKET

FIGURE 48. TOP PLAYER POSITIONING, 2022

FIGURE 49. NIPPON SANSO HOLDINGS CORPORATION: NET REVENUE, 2020-2022 ($MILLION)

FIGURE 50. NIPPON SANSO HOLDINGS CORPORATION: REVENUE SHARE BY SEGMENT, 2022 (%)

FIGURE 51. AIR PRODUCTS AND CHEMICALS, INC.: NET REVENUE, 2020-2022 ($MILLION)

FIGURE 52. AIR PRODUCTS AND CHEMICALS, INC.: REVENUE SHARE BY SEGMENT, 2022 (%)

FIGURE 53. AIR PRODUCTS AND CHEMICALS, INC.: REVENUE SHARE BY REGION, 2022 (%)

FIGURE 54. DCC PLC: NET REVENUE, 2021-2023 ($MILLION)

FIGURE 55. DCC PLC: REVENUE SHARE BY SEGMENT, 2023 (%)

FIGURE 56. DCC PLC: REVENUE SHARE BY REGION, 2023 (%)

FIGURE 57. LINDE PLC: NET SALES, 2020-2022 ($MILLION)

FIGURE 58. LINDE PLC: RESEARCH & DEVELOPMENT EXPENDITURE, 2020-2022 ($MILLION)

FIGURE 59. LINDE PLC: REVENUE SHARE BY SEGMENT, 2022 (%)

FIGURE 60. LINDE PLC: REVENUE SHARE BY REGION, 2022 (%)

FIGURE 61. MESSER HOLDING GMBH: NET REVENUE, 2020-2022 ($MILLION)

FIGURE 62. MESSER HOLDING GMBH: REVENUE SHARE BY REGION, 2022 (%)

FIGURE 63. PT SAMATOR INDO GAS TBK.: NET REVENUE, 2020-2022 ($MILLION)

FIGURE 64. PT SAMATOR INDO GAS TBK.: REVENUE SHARE BY SEGMENT, 2022 (%)

FIGURE 65. NOL GROUP: NET REVENUE, 2020-2022 ($MILLION)

FIGURE 66. SOL SPA: NET REVENUE, 2020-2022 ($MILLION)

FIGURE 67. SOL SPA: REVENUE SHARE BY SEGMENT, 2022 (%)

FIGURE 68. AIR LIQUIDE: NET REVENUE, 2020-2022 ($MILLION)

FIGURE 69. AIR LIQUIDE: REVENUE SHARE BY SEGMENT, 2022 (%)

FIGURE 70. AIR LIQUIDE: REVENUE SHARE BY REGION, 2022 (%